AKT1 and Familial prostate cancer: Beyond their biological significance, several of these enriched pathways—such as estrogen signaling, PI3K-Akt signaling, Wnt signaling, and endocrine resistance—are therapeutically actionable and have been linked to treatment resistance in prostate cancer.